Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103539720B reveals high-yield 1-phenylindole synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Advanced Pd-Cu catalytic method for phenanthrene compounds. Delivers high yield and purity for pharmaceutical manufacturing. Reliable supply chain partner.
Patent CN103804303B details a streamlined synthesis for EGFR inhibitors. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN116283937B reveals metal-free photocatalytic synthesis for high-purity aromatic secondary amines, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN120794988A reveals efficient chiral phosphoric acid catalysis for high-purity indole derivatives, offering significant supply chain and cost advantages.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN111592549B reveals a novel Rh-catalyzed [4+1] cyclization for quinazolinone derivatives, offering streamlined synthesis and cost reduction in API manufacturing.
Patent CN112724189A details a novel semi-synthetic route for Chenodeoxycholic Acid from waste bile acids, offering significant cost reduction and supply chain stability for API manufacturers.
Novel atmospheric pressure method for lubiprostone using triethylsilane. Reduces equipment costs and improves purity for pharmaceutical manufacturing.
Novel patent CN114805218B offers eco-friendly rosuvastatin intermediate synthesis. Reduces aluminum waste and avoids expensive DIBAL-H for reliable supply.
Novel metal-free synthesis of indoline derivatives via Kukhtin-Ramirez adduct. High yield, mild conditions, scalable for API intermediates and fine chemicals.
Patent CN114805218B reveals a novel synthesis route for Rosuvastatin Calcium Intermediate, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN113444702B reveals high-efficiency OYE1 mutant for Brivaracetam intermediate production, offering superior conversion and ee values for scalable API manufacturing.
Patent CN107935997A reveals a cost-effective Osimertinib route avoiding expensive chloropyrimidine. Enhance supply chain reliability with scalable manufacturing.
Patent CN114890912B reveals efficient nickel-catalyzed synthesis of fluorinated intermediates, offering cost reduction and scalable supply chain solutions for pharma.
Patent CN109134362B details a metal-free photocatalytic method for nitrogen heterocycles, offering cost-effective and scalable solutions for pharmaceutical intermediate manufacturing.
Novel asymmetric synthesis patent CN106496099B offers high purity lobeline intermediate with cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN106349150B reveals efficient Pd-catalyzed carbonylation. Enables cost reduction in API intermediate manufacturing with high purity and scalable processes for global supply chains.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Improved sildenafil synthesis patent CN106117212B offers high purity and cost reduction in API manufacturing for global supply chains.